DENTSPLY SIRONA (NASDAQ:XRAY) Price Target Cut to $28.00

DENTSPLY SIRONA (NASDAQ:XRAY) had its price objective cut by Evercore ISI from $35.00 to $28.00 in a report published on Tuesday, Benzinga reports. They currently have an outperform rating on the medical instruments supplier’s stock.

Other equities research analysts also recently issued research reports about the stock. Piper Sandler reiterated a neutral rating and issued a $32.00 target price (down previously from $35.00) on shares of DENTSPLY SIRONA in a research report on Friday, May 3rd. StockNews.com downgraded DENTSPLY SIRONA from a buy rating to a hold rating in a research note on Friday, May 3rd. Robert W. Baird dropped their target price on DENTSPLY SIRONA from $35.00 to $33.00 and set a neutral rating on the stock in a research report on Friday, May 3rd. Needham & Company LLC cut their price target on DENTSPLY SIRONA from $42.00 to $36.00 and set a buy rating for the company in a research note on Friday, May 3rd. Finally, The Goldman Sachs Group dropped their price objective on DENTSPLY SIRONA from $34.00 to $30.00 and set a neutral rating on the stock in a report on Monday, May 6th. Five equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, DENTSPLY SIRONA presently has an average rating of Moderate Buy and an average target price of $34.44.

DENTSPLY SIRONA Price Performance

Shares of NASDAQ:XRAY opened at $24.91 on Tuesday. The company’s fifty day moving average is $27.72 and its two-hundred day moving average is $31.72. The company has a market cap of $5.17 billion, a P/E ratio of -56.61, a price-to-earnings-growth ratio of 1.12 and a beta of 1.04. DENTSPLY SIRONA has a 12-month low of $24.71 and a 12-month high of $41.65. The company has a quick ratio of 0.97, a current ratio of 1.43 and a debt-to-equity ratio of 0.54.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings results on Thursday, May 2nd. The medical instruments supplier reported $0.42 earnings per share for the quarter, meeting the consensus estimate of $0.42. DENTSPLY SIRONA had a positive return on equity of 11.54% and a negative net margin of 2.41%. The firm had revenue of $953.00 million for the quarter, compared to analyst estimates of $969.45 million. During the same period in the previous year, the firm earned $0.39 earnings per share. DENTSPLY SIRONA’s quarterly revenue was down 2.6% on a year-over-year basis. Equities analysts expect that DENTSPLY SIRONA will post 2.02 earnings per share for the current fiscal year.

DENTSPLY SIRONA Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 12th. Stockholders of record on Friday, June 28th will be paid a $0.16 dividend. The ex-dividend date is Friday, June 28th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 2.57%. DENTSPLY SIRONA’s payout ratio is presently -145.45%.

Insider Activity at DENTSPLY SIRONA

In other DENTSPLY SIRONA news, Director Gregory T. Lucier purchased 3,577 shares of the company’s stock in a transaction on Friday, May 31st. The shares were bought at an average cost of $27.95 per share, with a total value of $99,977.15. Following the transaction, the director now directly owns 58,374 shares in the company, valued at approximately $1,631,553.30. The purchase was disclosed in a document filed with the SEC, which is available at this hyperlink. 0.52% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the stock. Verity Asset Management Inc. bought a new position in DENTSPLY SIRONA during the first quarter valued at about $294,000. Teachers Retirement System of The State of Kentucky increased its position in shares of DENTSPLY SIRONA by 6.2% during the first quarter. Teachers Retirement System of The State of Kentucky now owns 19,370 shares of the medical instruments supplier’s stock valued at $642,000 after purchasing an additional 1,130 shares during the period. Cetera Advisors LLC raised its stake in shares of DENTSPLY SIRONA by 18.6% in the first quarter. Cetera Advisors LLC now owns 17,052 shares of the medical instruments supplier’s stock valued at $566,000 after purchasing an additional 2,675 shares in the last quarter. Virtu Financial LLC bought a new position in DENTSPLY SIRONA in the first quarter worth $1,027,000. Finally, Comerica Bank boosted its stake in DENTSPLY SIRONA by 2.9% during the first quarter. Comerica Bank now owns 42,568 shares of the medical instruments supplier’s stock worth $1,413,000 after buying an additional 1,205 shares in the last quarter. Institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.